SENORES PHARMACEUTICALS
Back to Cashflow Statement
|
SENORES PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.33 Cr | ₹573 Cr | ₹87 Cr | ₹46 Cr | ₹36 Cr |
What is the latest Cash Flow from Financing Activities ratio of SENORES PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-1.33 Cr |
| Mar2025 | ₹573 Cr |
| Mar2024 | ₹87 Cr |
| Mar2023 | ₹46 Cr |
| Mar2022 | ₹36 Cr |
How is Cash Flow from Financing Activities of SENORES PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1.33 Cr | Negative | |
| Mar2025 | ₹573 Cr | 558.92 | |
| Mar2024 | ₹87 Cr | 88.06 | |
| Mar2023 | ₹46 Cr | 26.84 | |
| Mar2022 | ₹36 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SENORES PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SENORES PHARMACEUTICALS | ₹5,031.1 Cr | -4.9% | -9.2% | 40.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | -4.9% |
-9.2% |
40.6% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses